![Udayan Guha](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Udayan Guha
Directeur Technique/Scientifique/R&D chez
NEXTCURE, INC.
Fortune : - $ au 30/06/2026
Profil
Udayan Guha currently works at NextCure, Inc., as Chief Medical Officer from 2025.
Dr. Guha also formerly worked at TCR² Therapeutics, Inc., as Vice President & Head-Clinical Development from 2022 to 2023.
Dr. Guha received his graduate degree from All India Institute of Medical Sciences and doctorate degree from Albert Einstein College of Medicine, Inc.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
NEXTCURE, INC. -.--% | 22/04/2026 | 0 ( -.--% ) | - $ | 30/06/2026 |
Postes actifs de Udayan Guha
| Sociétés | Poste | Début |
|---|---|---|
| NEXTCURE, INC. | Directeur Technique/Scientifique/R&D | 01/03/2023 |
Anciens postes connus de Udayan Guha
| Sociétés | Poste | Fin |
|---|---|---|
| TCR2 THERAPEUTICS INC. | Corporate Officer/Principal | 01/04/2023 |
Formation de Udayan Guha
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
4
Relations au 1er degré
4
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 4 |
|---|---|
All India Institute of Medical Sciences
 All India Institute of Medical Sciences Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Albert Einstein College of Medicine, Inc.
 Albert Einstein College of Medicine, Inc. Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
NextCure, Inc.
 NextCure, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company which discovers and develops novel immuno medicines to treat cancer & immune related diseases | Health Technology |
TCR2 Therapeutics, Inc.
 TCR2 Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage cell therapy company which engages in the development of biological drugs and engineering T-cells for cancer therapy | Health Technology |
